“D.ONE DUAL THERAPY. ONBOARDING FOR NAIVE EXPERIENCE FOCUS ON TEST AND TREAT”

1. 1.Calza L et al.. Efficacy and Safety of Dolutegravir/Lamivudine in Antiretroviral Therapy-Naive People Living With HIV-1 and With High-Level Viremia. J Acquir Immune Defic Syndr.. 2025
   Articolo scientificoJ Acquir Immune Defic Syndr.Leggi il PDF gratuito
2. 2.Gagliardini R et al.. Icona Foundation Study Group. Effectiveness of dolutegravir-based vs boosted darunavir-based first-line 3-drug regimens in people with HIV with advanced disease: A trial emulation. Int J Infect Dis.. 2025
   Articolo scientificoInt J Infect Dis.Cerca su Google Scholar
3. 3.Figueroa MI et al.. DOLCE study group. Efficacy and Safety of Dual Therapy With Dolutegravir/Lamivudine in Treatment-naive Persons With CD4 Counts <200/mm3: 48-Week Results of the DOLCE Study. Clin Infect Dis.. 2026
   Articolo scientificoClin Infect Dis.Leggi il PDF gratuito

I link ai libri possono contenere un codice affiliato Amazon: in qualità di affiliato, ECM Finder potrebbe ricevere una commissione sugli acquisti idonei, senza alcun costo aggiuntivo per te. I link ai paper rimandano alla fonte scientifica (DOI, versione open-access o ricerca accademica).